Christopher Nishan Garabedian 4/A
4/A · AVI BIOPHARMA INC · Filed Jan 4, 2011
Insider Transaction Report
Form 4/AAmended
Christopher Nishan Garabedian
Director
Transactions
- Award
Stock Option (right to buy)
2011-01-03+1,900,000→ 1,900,000 totalExercise: $2.17Exp: 2021-01-03→ Common Stock (1,900,000 underlying)
Footnotes (3)
- [F1]The exercise price of this stock option was incorrectly stated in the reporting person's original Form 4.
- [F2]The date of earliest transaction, transaction date and expiration date were incorrectly stated in the reporting person's original Form 4.
- [F3]This option is exercisable at the rate of 25% of the shares on January 1, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on January 1, 2015.